Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.
Saros Therapeutics is working to enhance patients' response to immunotherapy.
Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors.
Histolix provides an intrinsically digital and slide-free histopathology solution.
Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.
Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.
MALCOVA is a medical device startup delivering novel hardware and AI-based software solutions to resolve needs in the radiology market.
Georgia Cancer Center provides industry-leading cancer research and care that benefits patients locally and globally.
Isabl develops cancer diagnostic tests based on whole genome and RNA sequencing data.
GigaMune is a biotech firm focused on engineered TCR-Treg cell therapies for autoimmune diseases, including Type 1 Diabetes.
Kovina Therapeutics operates as a pre-clinical biotechnology company.
Olive Oil is a biotechnology company that produces extra virgin olive oil.
Telehealth Research Center of Excellence is a cancer center that is engaged in improving cancer-related care and outcomes.
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
Flexomics helps to bridge genomic and functional analysis.
Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.
Immunicom is a biotechnology company.
InheRET empowering individuals to accurately identify their risk for hereditary conditions.
Pioneering in-human click chemistry against cancer
TumorGen is a biotechnology company.
Advanced Chemotherapy Technologies is a startup developing a device that can infuse chemotherapies into poorly vascularized tumors.
KinaRx is a biotech firm focuses on the development of novel kinase inhibitors for the treatment of Acute myeloid leukemia.
Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases.
National Cancer Institute has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Cancer Institute's top investment sectors include Biotechnology, Medical, Health Care, Therapeutics, Life Science. The firm invests across 21 different industry categories.
Among tracked funding rounds, Telehealth ReseArch Center of Excellence received $5.7M in a Grant round. National Cancer Institute's total known invested capital is $319.4M.
National Cancer Institute's average investment size is $3.9M across its portfolio of 99 companies.
Recent National Cancer Institute portfolio additions include Microvascular Therapeutics, Modifi Bio, Saros Therapeutics, Current Surgical, Histolix. These companies were founded in 2020 or later.